Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 168.66x is 72% below its 2-year average of 598.57x, near the low end of its 2-year range (-248.77x–3444.00x).
86.71% below its 12-month average of 1269.22x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 687.88x.
INTEREST COVERAGE RATIO
168.66x
INTEREST COVERAGE RATIO AVG TTM
1269.22x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-86.71%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.22x
median of 341 covered companies
CURRENT VS SECTOR MEDIAN
+4096.68%
vs the sector median at left
BillionToOne, Inc.
Market Cap
$5.10B
Interest Coverage Ratio
168.66x
TTM Avg
1269.22x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.15B
Interest Coverage Ratio
-55.80x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.16B
Interest Coverage Ratio
6.97x
TTM Avg
5.98x
3Y Avg
8.44x
5Y Avg
9.07x
Market Cap
$5.24B
Interest Coverage Ratio
-108.87x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.88B
Interest Coverage Ratio
-4.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.87B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.81B
Interest Coverage Ratio
-30.34x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BillionToOne, Inc. (BLLN) | $5.10B | 168.66x | 1269.22x | N/A | N/A |
| Erasca, Inc. (ERAS)vs › | $5.06B | N/A | N/A | N/A | N/A |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.15B | -55.80x | N/A | N/A | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.16B | 6.97x | 5.98x | 8.44x | 9.07x |
| Cogent Biosciences, Inc. (COGT)vs › | $5.24B | -108.87x | N/A | N/A | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.88B | -4.85x | N/A | N/A | N/A |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.87B | N/A | N/A | N/A | N/A |
| Doximity, Inc. (DOCS)vs › | $5.39B | N/A | N/A | N/A | N/A |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.81B | -30.34x | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.75B | 2.07x | 2.07x | 2.07x | 1.38x |
Interest Coverage
168.7x
Debt/Equity
0.27
Current Ratio
11.69
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 687.88x |
| 2026-03-31 | 1783.40x |
| 2025-12-31 | 3444.00x |
| 2025-09-30 | 481.65x |
| 2025-06-30 | -50.84x |
| 2025-03-31 | -57.88x |
| 2024-12-31 | -248.77x |
| 2024-09-30 | -29.94x |
| 2024-06-30 | -11.85x |
| 2024-03-31 | -11.96x |
